BioMarin Pharmaceutical revenue
BioMarin Pharmaceutical (BMRN) reported revenue of $3.22 B for fiscal year 2025, +12.9% compared with the year before. Over the last 12 months revenue was $3.66 B.
Revenue 2025$3.22 B
Change+12.9%
World rank#964
Market cap$11.90 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $3.22 B | +12.9% |
| 2024 | $2.85 B | +18.0% |
| 2023 | $2.42 B | +15.4% |
| 2022 | $2.10 B | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.